The Latest News
LivHOME, Inc., one of the nation’s largest providers of professionally led at-home care for seniors, announced today that it has appointed Richard (Rick) Slager to its Board of Directors. Slager will focus on seeking new opportunities for LivHOME to grow and develop as it continues bringing top quality care to seniors living at home.
AtriCure, Inc. (ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech (“Estech”).
Medical device manufacturer Vidacare Corporation of San Antonio, Texas has entered into a merger agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for $262.5 million plus Vidacare's net cash.
SupplyPro announces the promotion of Stan Sigman to EVP, Chief Revenue Officer and the creation of a global Customer Relationship Management Department including the promotion of Cari Palmer to VP, Chief Customer Relationship Management Officer (CCRMO).
SYNAGEVA BIOPHARMA™ ANNOUNCES ONE YEAR OF TREATMENT DATA WITH SEBELIPASE ALFA IN LATE ONSET LAL DEFICIENCY>
Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase (LAL) Deficiency. The data will be presented today by Reena Sharma, M.D., Consultant, Adult Inherited Metabolic Diseases, Salford Royal Hospital, U.K., during an oral presentation at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) annual meeting being held in London, U.K., May 8-11, 2013.
Vidacare Corporation Expands Sales Force by Nearly 30 Percent to Support International Commercialization>
Vidacare Corporation has increased its sales force by approximately 30 percent to support international commercialization of the company’s products directly through to the end user. The company has hired over 20 sales professionals to represent Vidacare product systems, including the EZ-IO Intraosseous Vascular Access System and the OnControl Bone Marrow and Bone Access Systems, in targeted international markets.
Vidacare Corporation Launches iPhone App to Assist Health Care Professionals With Intraosseous Vascular Access>
Vidacare Corporation has launched a free point-of-care app for health care professionals to answer clinical and training questions related to its EZ-IO® Intraosseous Vascular Access System. The app is now available for download at the Apple iTunes Store and features interactive guides, videos and instructions on using the EZ-IO to obtain intraosseous vascular access.
Vidacare’s EZ-IO Intraosseous Vascular Access System Featured on National Geographic Channel’s Inside Combat Rescue>
The EZ-IO® Intraosseous Vascular Access System by San Antonio-based Vidacare Corporation was featured in the premiere of the National Geographic Channel’s six-part documentary miniseries Inside Combat Rescue on February 18.
Vidacare Corporation has expanded its management team with the hiring of three executives and the promotion of a fourth.
Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced that the first patient initiated treatment in the ARISE trial (Acid Lipase Replacement Investigating Safety and Efficacy), a global, Phase 3, randomized, double-blind, placebo-controlled study of sebelipase alfa in children and adults with late onset lysosomal acid lipase deficiency (LAL Deficiency).
Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013. Mark Goldberg, MD, Senior Vice President, Medical and Regulatory Affairs, is scheduled to present on Wednesday, February 13, 2013, at 9:00 AM EST.
SYNAGEVA BIOPHARMA ANNOUNCES CLOSING OF PUBLIC OFFERING AND EXERCISE OF OPTION TO PURCHASE ADDITIONAL SHARES>
LEXINGTON, Mass., January 9, 2013 -- Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the closing of a $118 million underwritten public offering of 2,472,500 shares of common stock, including 322,500 shares of common stock which were issued pursuant to the exercise of the underwriters’ option to purchase additional shares, at a price of $47.53 per share.
LOS ANGELES--(BUSINESS WIRE)-- LivHOME CareMonitor™ (www.livhomecaremonitor.com), a remote care service first announced in March, is beginning to roll out nationwide where LivHOME services are offered. It is currently available in Los Angeles, Walnut Creek and Riverside, Calif., and will continue to be rolled out to additional markets in late 2012 and early 2013. LivHOME CareMonitor™ is provided by LivHOME, Inc., one of the nation’s largest providers of professionally led at-home care for seniors.
Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced six month results from an ongoing extension study of sebelipase alfa in adults with late onset Lysosomal Acid Lipase (LAL) Deficiency at the American Association for the Study of Liver Diseases (AASLD) annual meeting being held in Boston, MA, November 9-13, 2012.
The Wall Street Journal announced the winners of its 2012 Technology Innovation Awards today, and for the second time, Vidacare Corporation has been recognized for its ground-breaking technology. Vidacare’s OnControl Bone Marrow System is the overall Bronze winner in this year’s Technology Innovation Awards and the winner of the Medical Devices category. Vidacare’s EZ-IO Intraosseous Infusion System won the overall Gold Technology Innovation of the Year award from the same program in 2008.
On the heels of a recent expanded FDA indication to allow for “bone biopsy of the vertebral body and bone lesions,” Vidacare Corporation’s OnControl Bone Access System has developed a new extension of its technology platform. The OnControl Bone Access System Coaxial Biopsy Tray for powered bone biopsy provides a tool for clinicians to access hard bones and perform biopsies of bone lesions using the company's innovative power-driver and specially engineered needle.
Exagen Diagnostics Inc . said it raised $5.3 million to finance market expansion and development of near-term pipeline products. Tullis Health Investors led the round. Other investors include Cottonwood Technology Fund, Epic Ventures , Mesa Verde Venture Partners and Sun Mountain Capital.
SupplyPro, the premier provider of Point-of-Use (POU) inventory management solutions, today announced the release of two new devices, the SupplyChiller and the SupplyPad.
Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion™ ablation system. This revolutionary technology is the first of its kind to use a unique suction application and innovative electrode configuration to gently pull the tissue targeted for ablation into the device and out of the path of circulating blood.
Vidacare Founder Larry Miller, MD to receive prestigious BioMed SA 2012 Julio Palmaz Award for Innovation in Healthcare and the Biosciences>
In recognition of his contributions to the field of medicine and his pioneering role in using intraosseous vascular access to improve patient care and save lives on a global basis, the Founder and Chief Medical Officer of Vidacare Corporation, Dr. Larry Miller, is the 2012 recipient of the prestigious BioMed SA Julio Palmaz Award for Innovation in Healthcare and the Biosciences.